<DOC>
	<DOCNO>NCT01232348</DOCNO>
	<brief_summary>The purpose study confirm safety ( ADR relate beta stimulant drug , unexpected ADRs ) efficacy Symbicort daily practice control status bronchial asthma Patient satisfaction</brief_summary>
	<brief_title>Symbicort Turbuhaler 30/60 Clinical Experience Investigation</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Patients treat Symbicort first time due bronchial asthma</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>bronchial asthma</keyword>
	<keyword>Symbicort</keyword>
</DOC>